Showing results (2111-2120 of 2,138) with videos related to

Sort By:
Pageof 214
Science (New York, N.Y.)|April 9, 2026
Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunityJooho Chung, Mounica Vallurupalli, Sarah Noel, et al.
Cancer Cell|July 16, 2015
Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic LeukemiaShuo-Chieh Wu, Loretta S Li, Nadja Kopp, et al.
Blood|September 21, 2022
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemiaEric J Duncavage, Adam Bagg, Robert P Hasserjian, et al.
The New England Journal of Medicine|June 5, 2018
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AMLCourtney D DiNardo, Eytan M Stein, Stéphane de Botton, et al.
JAMA Psychiatry|June 24, 2026
Neurometabolites and Antipsychotic Response in Psychosis: A Mega-AnalysisBridget King, Kirsten Borup Bojesen, Charlotte Crisp, et al.
The New England Journal of Medicine|July 24, 2024
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in AdultsMark R Litzow, Zhuoxin Sun, Ryan J Mattison, et al.
The Lancet. Haematology|December 16, 2019
Alisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: a single-arm, phase 2 trialAndrew M Brunner, Traci M Blonquist, Daniel J DeAngelo, et al.
Journal for Immunotherapy of Cancer|December 27, 2016
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemiaMichael Boyiadzis, Michael R Bishop, Rafat Abonour, et al.
The Lancet. Haematology|June 22, 2020
Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international expertsAmer M Zeidan, Prajwal C Boddu, Mrinal M Patnaik, et al.
Pharmacogenetics and Genomics|November 1, 2024
The Pharmacogenomics Global Research Network Implementation Working Group: global collaboration to advance pharmacogenetic implementationLarisa H Cavallari, J Kevin Hicks, Jai N Patel, et al.
Pageof 214